Patient Information:
- Patient ID: 10019003
- Admission ID: 25508812
- Patient Name: Amir Ahmadi
- Patient Age: 65

Initial Diagnosis:
Based on clinical presentation and laboratory results, the primary concern is a severe respiratory infection.

History of Present Illness (HPI):
Mr. Amir Ahmadi, a 65-year-old male, was admitted to the hospital with symptoms suggestive of an acute respiratory infection. He presented with fever, dry cough, and progressive shortness of breath over five days. The patient denies any known exposure to COVID-19 or recent travel.

Past Medical History (PMH):
The patient has a history of hypertension, hyperlipidemia, and type 2 diabetes mellitus. He is currently on metformin, lisinopril, and atorvastatin.

Medications:
At the time of admission, medications include metformin 500 mg twice daily, lisinopril 10 mg once daily, and atorvastatin 20 mg once daily.

Family History (FH):
There is no known family history of similar respiratory infections or conditions that could predispose the patient to this current illness.

Social History (SH):
The patient is married with three children. He works as an accountant in a private firm. He denies smoking, alcohol consumption, and illicit drug use.

Physical Examination (PE):
Vital signs at admission included tachypnea (22 breaths per minute), fever (38.6Â°C), and hypoxemia (oxygen saturation 88% on room air). Chest X-ray revealed bilateral infiltrates consistent with pneumonia. Laboratory tests indicated elevated white blood cell count, C-reactive protein, and procalcitonin levels.

Initial Diagnosis:
The patient's clinical presentation, laboratory findings, and imaging results suggest a severe respiratory infection secondary to COVID-19 virus.

Plan (Treatment & Management):
The patient was admitted under isolation precautions and placed on supplemental oxygen. Intravenous antibiotics were initiated considering potential bacterial superinfection. Supportive care includes hydration and monitoring vital signs closely. The infectious disease team will be consulted for further evaluation and management based on ongoing test results, including COVID-19 PCR and serology.

Further updates will be provided as the clinical situation evolves.